2023 Was a tricky yr for the biopharma industry, with numerous corporations downsizing and restructuring their workforces to stay afloat. There are indications of Restoration, as mergers and acquisitions picked up throughout the pharmaceutical and existence sciences industry during the latter Section of 2023 and have continued their upswing into https://sites.google.com/view/bio-sites/blog